FR3183M - Médicament présentant une activité vitaminique b6 et utilisable notamment contre les affections de l'épiderme et du derme, a base de di-acyl-3,4-pyridoxines. - Google Patents

Médicament présentant une activité vitaminique b6 et utilisable notamment contre les affections de l'épiderme et du derme, a base de di-acyl-3,4-pyridoxines.

Info

Publication number
FR3183M
FR3183M FR922836A FR922836A FR3183M FR 3183 M FR3183 M FR 3183M FR 922836 A FR922836 A FR 922836A FR 922836 A FR922836 A FR 922836A FR 3183 M FR3183 M FR 3183M
Authority
FR
France
Prior art keywords
pyridoxines
dermis
epidermis
acyl
activity
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
FR922836A
Other languages
English (en)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Nihon Surfactant Industries Co Ltd
Original Assignee
Nihon Surfactant Industries Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nihon Surfactant Industries Co Ltd filed Critical Nihon Surfactant Industries Co Ltd
Application granted granted Critical
Publication of FR3183M publication Critical patent/FR3183M/fr
Active legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/62—Oxygen or sulfur atoms
    • C07D213/63—One oxygen atom
    • C07D213/65—One oxygen atom attached in position 3 or 5
    • C07D213/66—One oxygen atom attached in position 3 or 5 having in position 3 an oxygen atom and in each of the positions 4 and 5 a carbon atom bound to an oxygen, sulphur, or nitrogen atom, e.g. pyridoxal
    • C07D213/67—2-Methyl-3-hydroxy-4,5-bis(hydroxy-methyl)pyridine, i.e. pyridoxine

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pyridine Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
FR922836A 1961-10-30 1963-01-28 Médicament présentant une activité vitaminique b6 et utilisable notamment contre les affections de l'épiderme et du derme, a base de di-acyl-3,4-pyridoxines. Active FR3183M (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP3873661 1961-10-30
FR913868A FR1501705A (fr) 1961-10-30 1962-10-30 Di-acyl-3, 4 pyridoxines et leur procédé de préparation

Publications (1)

Publication Number Publication Date
FR3183M true FR3183M (fr) 1965-03-15

Family

ID=12533597

Family Applications (2)

Application Number Title Priority Date Filing Date
FR913868A Expired FR1501705A (fr) 1961-10-30 1962-10-30 Di-acyl-3, 4 pyridoxines et leur procédé de préparation
FR922836A Active FR3183M (fr) 1961-10-30 1963-01-28 Médicament présentant une activité vitaminique b6 et utilisable notamment contre les affections de l'épiderme et du derme, a base de di-acyl-3,4-pyridoxines.

Family Applications Before (1)

Application Number Title Priority Date Filing Date
FR913868A Expired FR1501705A (fr) 1961-10-30 1962-10-30 Di-acyl-3, 4 pyridoxines et leur procédé de préparation

Country Status (5)

Country Link
US (1) US3186996A (fr)
CH (1) CH414633A (fr)
DE (1) DE1296140B (fr)
FR (2) FR1501705A (fr)
GB (1) GB965844A (fr)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3317518A (en) * 1964-10-01 1967-05-02 Hoffmann La Roche Novel 5-aryl-1, 2, 4, 5-tetrahydrobenzo-diazepin-3-one compounds
CN107935923A (zh) * 2017-11-09 2018-04-20 华中药业股份有限公司 一种吡哆醇二棕榈酸酯的合成方法

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2897203A (en) * 1959-07-28 Chacoo
US2399959A (en) * 1942-07-02 1946-05-07 Procter & Gamble Process of producing esters
US2955115A (en) * 1955-06-13 1960-10-04 Fred A Kummerow Long-chain fatty acid esters of vitamin b6

Also Published As

Publication number Publication date
FR1501705A (fr) 1967-11-18
GB965844A (en) 1964-08-06
US3186996A (en) 1965-06-01
CH414633A (fr) 1966-06-15
DE1296140B (de) 1969-05-29

Similar Documents

Publication Publication Date Title
DK111148B (da) Aerosol-sprøjtepræparat med desinficerende og kosmetisk virkning til anvendelse i kvindehygiejne.
DK131088B (da) Filmformet salvepræparat til dermatologisk behandling af hudflader samt fremgangsmåde til fremstilling deraf.
DK105776C (da) Hudrense- og hudplejemiddel.
FR2261M (fr) Médicament préventif et curatif pour diverses maladies de la peau.
FR3183M (fr) Médicament présentant une activité vitaminique b6 et utilisable notamment contre les affections de l'épiderme et du derme, a base de di-acyl-3,4-pyridoxines.
BE582650A (fr) Produits médicaux et particulièrement préparations pharmaceutiques
FR2463M (fr) Médicament a base d'un dérivé de la 2.4-diaminopyrido[2.3-d]-pyrimidine, utilisable notamment contre les infections microbiennes.
NL139739B (nl) Werkwijze voor het bereiden van therapeutische werkzame 3,4,5-trimethoxybenzoezuuramiden, werkwijze voor het bereiden van farmaceutische preparaten die deze verbindingen bevatten en gevormde farmaceutische preparaten, verkregen onder toepassing van laatstgenoemde werkwijze.
FR2015M (fr) Perfectionnements aux préparations pharmaceutiques.
FR137M (fr) Médicament, ayant en particulier une activité lipotrope et tonique, ? l'ergothionéine.
FR1242M (fr) Médicament, utilisable notamment pour le traitement des affections fongiques, a base de dérivés de la griséofulvine.
OA01368A (fr) Préparations pharmaceutiques à action anthelmintique.
FR1573M (fr) Substance médicamenteuse contre la séborrhée et pour le traitement du cuir chevelu.
DK127742B (da) Kosmetisk hår- og hudbehandlingsmiddel.
FR1180M (fr) Médicament a base d'un dérivé de l'uracyle, destiné notamment au traitement de l'hyperuricémie et de l'hypercholestérolémie.
FR2014M (fr) Médicament pour le traitement de l'eczéma et autres maladies cutanées, en particulier des affections causes de calvitie.
FR1722M (fr) Médicaments nouveaux constitués par des 4-(pyridoylamido-acylamino)-1-phényl-2,3-diméthyl-pyrazolones-(5).
FR3392M (fr) Médicament dermatologique, notamment pour le traitement de l'eczéma suintant.
FR1204M (fr) Nouveau médicament, notamment pour le traitement de l'hyperlipémie chronique ou post-prandiale.
FR1143M (fr) Médicament a base de dérivé pyimidique, notamment pour le traitement de l'hypercholestérolémie et de l'hyper-uricémie.
FR1317M (fr) Nouveau médicament convenant notamment au traitement des affections intestinales.
GB1194912A (en) Pharmaceutical Compositions Suitable for Cicatrization Processes and for the Treatment of Physiological Disorders of the Skin
FR1412M (fr) Nouveau médicament notamment pour le traitement des bronchites, pneumonies, collapsus cardiaques et défaillances cardiaques.
FR1174M (fr) Médicament a base de complexes de bismuth et de sulfanilamide, notamment pour le traitement des angines.
FR2219M (fr) Produit nouveau assurant la pousse des cheveux et des poils.